Xia, Zong-jun
Ji, Yin-chun
Sun, De-qiao
Peng, Xia
Gao, Ying-lei
Fang, Yan-fen
Zhao, Xing-dong
Wang, Wei-bo
Ding, Jian
Geng, Mei-yu
Ai, Jing
Article History
Received: 4 June 2020
Accepted: 17 August 2020
First Online: 11 September 2020
Competing interests
: WBW is a co-founder and shareholder of Fochon Pharmaceuticals, a company developing the SAF-189s; and XDZ is a full-time employee of Fochon Pharmaceuticals. The other authors declare that they have no competing interest.